Brands Push Back Against REMS Reform, Call Problem Small With Burdensome Fixes

BIO cautioned that its members may have difficulties meeting the purchase orders of product for generic sponsors, while PhRMA contended legislation is not necessary.

More from Generics

More from Biosimilars & Generics